Patents by Inventor Crina Tiron

Crina Tiron has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • BELT STRAP FOR A SAFETY BELT DEVICE OF A MOTOR VEHICLE
    Publication number: 20230235489
    Abstract: The invention relates to a belt strap for a safety belt device of a motor vehicle, comprising at least one hollow section which has at least one cavity for receiving electronic components and/or lines, wherein the cavity is formed by two fabric layers and the fabric layers are formed by a plurality of warp threads and weft threads. The fabric layers are connected to each other in the outer edge sections by means of edge weave threads. A single layer section adjoins the at least one hollow section, in which the fabric layers are connected to each other by a plurality of central weave threads, the central weave threads in the hollow section being woven together in only one of the fabric layers.
    Type: Application
    Filed: April 13, 2021
    Publication date: July 27, 2023
    Inventors: Ioan IONITA, Kai-Stephan MUELLER, Crina TIRON, Willi WELZ, Mihaela COSTEA
  • METHOD
    Publication number: 20200072839
    Abstract: The use of Akt3 as a biomarker for detecting the occurrence of epithelial-to-mesenchymal transition (EMT) in a subject, and the use of Akt3 inhibitors to treat cancer is disclosed herein. Also disclosed are various methods for detecting the occurrence of epithelial-to-mesenchymal transition (EMT) in a subject by measuring Akt3 expression and/or activity.
    Type: Application
    Filed: May 10, 2019
    Publication date: March 5, 2020
    Applicant: BERGENBIO ASA
    Inventors: Jim Lorens, Crina Tiron
  • Methods of detecting Akt3 and administering Ax1 inhibitor
    Patent number: 10317405
    Abstract: The use of Akt3 as a biomarker for detecting the occurrence of epithelial-to-mesenchymal transition (EMT) in a subject, and the use of Akt3 inhibitors to treat cancer is disclosed herein. Also disclosed are various methods for detecting the occurrence of epithelial-to-mesenchymal transition (EMT) in a subject by measuring Akt3 expression and/or activity.
    Type: Grant
    Filed: May 2, 2013
    Date of Patent: June 11, 2019
    Assignee: BERGENBIO ASA
    Inventors: Jim Lorens, Crina Tiron
  • METHOD
    Publication number: 20150119475
    Abstract: The use of Akt3 as a biomarker for detecting the occurrence of epithelial-to-mesenchymal transition (EMT) in a subject, and the use of Akt3 inhibitors to treat cancer is disclosed herein. Also disclosed are various methods for detecting the occurrence of epithelial-to-mesenchymal transition (EMT) in a subject by measuring Akt3 expression and/or activity.
    Type: Application
    Filed: May 2, 2013
    Publication date: April 30, 2015
    Inventors: Jim Lorens, Crina Tiron